(Q42831503)

English

Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon ? gene therapy in combination with adoptive chemoimmunotherapy

scientific article published on January 1, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon alpha gene therapy in combination with adoptive chemoimmunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon ? gene therapy in combination with adoptive chemoimmunotherapy (English)

1 reference

10.1007/BF01218361

https://api.crossref.org/works/10.1007/BF01218361

8 July 2024

0 references

interferon-alpha

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

author name string

X. Cao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

J. Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

W. Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

G. Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

X. Kong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

K. Tani

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642687

8 July 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01218361.pdf

Portable Document Format

1 reference

10.1007/BF01218361

https://api.crossref.org/works/10.1007/BF01218361

8 July 2024

http://link.springer.com/article/10.1007/BF01218361/fulltext.html

1 reference

10.1007/BF01218361

https://api.crossref.org/works/10.1007/BF01218361

8 July 2024

http://link.springer.com/content/pdf/10.1007/BF01218361

1 reference

10.1007/BF01218361

https://api.crossref.org/works/10.1007/BF01218361

8 July 2024

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

457-462

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

https://scigraph.springernature.com/pub.10.1007/bf01218361

0 references

Autologous fibroblast implantation. Feasibility and potential problems in gene replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implantation of genetically engineered fibroblasts into mice: implications for gene therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An alternative approach to somatic cell gene therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

55 Cytopathic effect inhibition assay for interferon: Microculture plate assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implantation of genetically manipulated fibroblasts into mice as antitumor alpha-interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7642687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular Biology and Medicine

6

7

461

author name string

PL Chang

publication date

1990

1 reference

10.1007/BF01218361

https://api.crossref.org/works/10.1007/BF01218361

8 July 2024

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

14

1 reference

10.1007/BF01218361

https://api.crossref.org/works/10.1007/BF01218361

8 July 2024

Identifiers

10.1007/BF01218361

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42831503&oldid=2198266393"